Apoptosis and traumatic brain injury

Neurocritical Care

Volumn 3, Issue 2, 2005, Pages 177-182

  Wong, Jill ^a   Ng, Wai Hoe ^a   Zhiwei, Feng ^b   Ng, Ivan ^a,c  

^a Department of Neurosurgery   (Singapore)

^b National Neuroscience Institute   (Singapore)

^c NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

Author keywords

Apoptosis; Bcl 2 family; Caspases; Fas; Therapeutic intervention; Traumatic brain injury

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE; CASPASE 3; CASPASE 9; FAS ANTIGEN; FAS LIGAND; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RAS PROTEIN;

APOPTOSIS; ARTICLE; BRAIN INJURY; DNA DAMAGE; DNA SEQUENCE; HUMAN; ISOELECTRIC FOCUSING; LITERATURE; NONHUMAN; PATHOGENESIS; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; BRAIN INJURIES; HUMANS;

EID: 24944466380     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/NCC:3:2:177     Document Type: Article

References (58)

1. Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: management protocol and clinical results. J Neurosurg. 1995;83:949-962.
2. Rosner MJ. Introduction to cerebral perfusion pressure management. Neurosurg Clin N Am 1995;6:761-773.
3. Cruz J. The first decade of continuous monitoring of jugular bulb oxyhemoglobin saturation: management strategies and clinical outcome. Crit Care Med 1998;26:344-351.
4. Czosnyka M, Smielewski P, Czosnyka Z, et al. Continuous assessment of cerebral autoregulation: clinical and laboratory experience. Acta Neurochir Suppl 2003;86:581-585.
5. Steiner LA, Coles JP, Johnston AJ, et al. Assessment of cerebrovascular autoregulation in head-injured patients: a validation study. Stroke 2003;34:2404-2409.
6. Zuzarte-Luis V, Hurle JM. Programmed cell death in the developing limb. Int J Dev Biol 2002;46:871-876.
7. Gorczyca W, J Gong, Z Darzynkiewicz. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993;53:1945-1951.
8. Kerr JFR, Wyllie AH, Currie AR Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
9. Rideout HJ, Stefanis L. Caspase inhibition: a potential therapeutic strategy in neurological diseases. Histol Histopathol 2001;16:895-908.
10. Newcomb JK, Zhao X, Pike BR, Hayes RL. Temporal profile of apoptotic-like changes in neurons and astrocytes following controlled cortical impact injury in the rat. Exp Neurol 1999;158:76-88.
11. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular biology of the cell, 4th ed. New York: Garland Science, 2002:983-1064.
12. Lodish HA, Berk SL, Matsudaira P, et al. Molecular Cell Biology, 4th ed. New York: W.H. Freeman, 2000:1054-1084.
13. Dexter TM, Raff MC, Wyllie AH. The role of apoptosis in development, tissue homeostasis and malignancy: death from inside out. London: Chapman & Hall: The Royal Society, 1995:1-45.
14. Raff MC. Social controls on cell survival and cell death. Nature 1992;356:397-399.
15. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
16. Bortner CD, Oldenburg NBE, Cidlowski JA. The role of DNA fragmentation in apoptosis. Trends Cell Biol. 1995;5:21-26.
17. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995;184:39-51.
18. Gorczyca W, Tuziak T, Kram A, Melamed MR, Darzynkiewicz Z. Detection of apoptosis-associated DNA strand breaks in fine-needle aspiration biopsies by in situ end labeling of fragmented DNA. Cytometry 1994;15:169-175.
19. + thymocytes by flow cytometry. J. Immunol Methods 1991;137:79-87.
20. Sachs LM, Abdallah B, Hassan A, et al. Apoptosis in Xenopus tadpole tail muscles involves Bax-dependent pathways. FASEB J 1997;11:801-808.
21. Cande C, Cecconi F, Dessen P, Kroemer G. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J Cell Sci 2002;115:4727-1734.
22. Furth PA, Bar-Peled U, Li M. Apoptosis and mammary gland involution: reviewing the process. Apoptosis 1997;2:19-24.
23. Yazdanbakhsh K, Choi JW, Li Y, Lau LF, Choi Y. Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77. Proc Natl Acad Sci USA 1995;92:437-441.
24. Grodzicky T, Elkon KB. Apoptosis: a case where too much or too little can lead to autoimmunity. Mt Sinai J Med 2002;69:208-219.
25. Curtin JF, Cotter TG. Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal 2003;15:983-992.
26. Darzynkiewicz Z, Li X, Gong J. Assay of cell viability: discrimination of cells dying by apoptosis. In: Darzynkiewicz Z, Robinson JP, Crissman HA, eds. Flow cytometry, 2nd ed. Academic Press, New York, 1994:15-38.
27. Berger RP, Pierce MC, Wisniewski SR, et al. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 2002;109:E31.
28. Raghupathi R, Graham DI, McIntosh TK. Apoptosis after traumatic brain injury. J Neurotrauma 2000;17:927-938.
29. Liou AK, Clark RS, Henshall DC, Yin XM, Chen J. To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog Neurobiol 2003;69:103-142.
30. Zhang X, Chen J, Graham SH, et al. Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J Neurochem 2002;82:181-191.
31. Lenzlinger PM, Marx A, Trentz O, Kossmann T, Morganti-Kossmann MC. Prolonged intrathecal release of soluble Fas following severe traumaticbrain injury in humans. J Neuroimmunol 2002;122:167-174.
32. Keane RW, Kraydieh S, Lotocki G, Alonso OF, Aldana P, Dietrich WD. Apoptotic and antiapoptotic mechanisms after traumatic brain injury. J Cereb Blood Flow Metab 2001;21:1189-1198.
33. Beer R, Franz G, Schopf M, et al. Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J Cereb Blood Flow Metab 2000;20:669-677.
34. Peli J, Schroter M, Rudaz C, et al. Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J 1999;18:1824-1831.
35. Maecker HL, Koumenis C, Giaccia AJ. p53 promotes selection for Fas-mediated apoptotic resistance. Cancer Res 2000;60:4638-4644.
36. Zhang X, Graham SH, Kochanek PM, et al. Caspase-8 expression and proteolysis in human brain after severe head injury. FASEB J 2003;17:1367-1369.
37. Knoblach SM, Nikolaeva M, Huang, et al. Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome. J Neurotrauma 2002;19:1155-1170.
38. Robertson GS, Crocker SJ, Nicholson DW, Schulz JB. Neuroprotection by the inhibition of apoptosis. Brain Pathol 2000;10:283-292.
39. Clark RS, Chen J, Watkins SC, et al. Apoptosis-suppressor gene bcl-2 expression after traumatic brain injury in rats. J Neurosci 1997;17:9172-9182.
40. Clark RS, Kochanek PM, Chen M, et al. Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J 1999;13:813-821.
41. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997;275:1129-1132.
42. Vink R, Nimmo AJ, Cernak I. An overview of new and novel pharmacotherapies for use in traumatic brain injury. Clin Exp Pharmacol Physiol 2001;28:919-921.
43. Beer R, Franz G, Srinivasan A, et al. Temporal profile and cell subtype distribution of activated caspase-3 following experimental traumatic brain injury. J Neurochem 2000;75:1264-1273.
44. Eldadah BA, Faden AI. Caspase pathways, neuronal apoptosis and CNS injury. J Neurotrauma 2000;17:811-829.
45. Clark RS, Kochanek PM, Watkins SC, et al. Caspase-3 mediated neuronal death after traumatic brain injury in rats. J Neurochem 2000;74:740-753.
46. Sanchez Mejia RO, Ona VO, Li M, Friedlander RM. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 2001;48:1393-1399.
47. Szabo I, Zoratti M. The giant channel of the inner mitochondrial membrane is inhibited by cyclosporin A. J Biol Chem 1991;266:3376-3379.
48. Suvillian PG Rabchevsky AG, Hicks RR, Gibson TR, Fletcher-Turner A, Scheff SW. Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 2000;101:289-295.
49. Buki A, Okonkwo DO, Povlishock JT. Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury. J Neurotrauma 1999;16:511-521.
50. 2+-MAPK/ERK pathways. J Neurochem 2003;87:508-521.
51. LaPlaca MC, Zhang J, Raghupathi R, et al. Pharmacologic inhibition of poly (ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats. Neurotrauma 2001;18:369-376.
52. Movsesyan VA, Yakovlev AG, Fan L, Faden AI. Effect of serine protease inhibitors on posttraumatic brain injury and neuronal apoptosis. Exp Neurol 2001;167:366-375.
53. Lewen A, Skoglosa Y, Clausen F, et al. Paradoxical increase in neuronal DNA fragmentation after neuroprotective free radical scavenger treatment in experimental traumatic brain injury. J Cereb Blood Flow Metab 2001;21:344-350.
54. Sullivan PG, Keller JN, Bussen WL, Scheff SW. Cytochrome c release and caspase activation after traumatic brain injury. Brain Res 2002;949:88-96.
55. Lewen A, Fujimura M, Sugawara T, Matz P, Copin JC, Chan PH. Oxidative stress-dependent release of mitochondrial cytochrome c after traumatic brain injury. J Cereb Blood Flow Metab 2001;21:914-920.
56. Yakovlev AG, Di X, Movsesyan V, et al. Presence of DNA fragmentation and lack of neuroprotective effect in DFF45 knockout mice subjected to traumatic brain injury. Mol Med 2001;7:205-216.
57. Nathoo N, Narotam PK, Agrawal DK, Connolly CA, van Dellen JR, Barnett GH, Chetty R. Influence of apoptosis on neurological outcome following traumatic cerebral contusion. J Neurosurg 2004;101:233-240.
58. Eastman P. Why neuroprotective drugs fail: questions about cell death present new challenges. Neurol Today. August 2003.